State Street reports 5.3% passive stake in CareDx
State Street Corporation has filed a Schedule 13G reporting a passive ownership stake in CareDx, Inc. (CDNA).
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
State Street Corporation has filed a Schedule 13G reporting a passive ownership stake in CareDx, Inc. (CDNA). As of 12/31/2025, State Street reports beneficial ownership of 2,737,752 shares of CareDx common stock, representing 5.3% of the outstanding class.
State Street reports shared voting power over 2,606,232 shares and shared dispositive power over 2,737,752 shares, with no sole voting or dispositive power. The position is held through investment management affiliates, including SSGA Funds Management and various State Street Global Advisors entities, and is certified as being held in the ordinary course of business without the purpose of influencing control.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does State Street Corporation report in its Schedule 13G for CareDx (CDNA)?
Is State Street’s CareDx (CDNA) stake intended to influence control of the company?
Which State Street affiliates are associated with the CareDx (CDNA) holdings?
Why did State Street file a Schedule 13G instead of a Schedule 13D for CareDx (CDNA)?
AI-generated analysis. How Rhea-AI works. Not financial advice.